Loading...

GALERA THERAPEUTICS INC Management Changes 8-K Filing

GLR

GALERA THERAPEUTICS INC

()

2025 8-K

Annual Meeting Notice

Preferred Stock Amendment

Executive Bonus Agreement

Asset Sale Agreement

Asset Sale Agreement

Royalty Agreement Update

Agreement Amendment

Acquisition Completed

Director Elections

External Links:

At the annual meeting on February 24, 2025, Galera Therapeutics' stockholders elected two directors for three-year terms and ratified KPMG LLP as their accounting firm for 2024, with 41,342,291 votes in favor of KPMG's appointment.

AI Assistant

GALERA THERAPEUTICS INC

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.